Masaki Kubozono - Publications

Consolidation reduced-dose whole-brain radiation therapy with response-adapted boost in older patients with newly diagnosed primary central nervous system lymphoma.

Journal: Journal of neuro-oncology

Published: December 27, 2025

Clinical significance of completion of radium-223 treatment and acute adverse events in patients with metastatic castration-resistant prostate cancer.

Journal: Asia Oceania journal of nuclear medicine & biology

Published: August 31, 2022

Palliative radiotherapy for gastric cancer bleeding: a multi-institutional retrospective study.

Journal: BMC palliative care

Published: December 15, 2021

Recurrence of Lymph Node Micrometastases After Radiotherapy for Head and Neck Carcinoma: A Propensity Score-matched Study.

Journal: Cancer diagnosis & prognosis

Published: March 28, 2021

Clinical experience of pelvic radiotherapy or chemoradiotherapy for postoperative uterine cervical cancer using intensity-modulated radiation therapy.

Journal: Journal of radiation research

Published: December 19, 2019

Quantitative analysis of intra-fractional variation in CT-based image guided brachytherapy for cervical cancer patients.

Journal: Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)

Published: December 15, 2019

Prognostic Value of Radiation Pneumonitis After Stereotactic Body Radiotherapy: Effect of Pulmonary Emphysema Quantitated Using CT Images.

Journal: Clinical lung cancer

Published: March 28, 2017

Evaluation of rectum and bladder dose accumulation from external beam radiotherapy and brachytherapy for cervical cancer using two different deformable image registration techniques.

Journal: Journal of radiation research

Published: January 30, 2017

Definitive Chemoradiotherapy for Advanced Pulmonary Sarcomatoid Carcinoma.

Journal: Internal medicine (Tokyo, Japan)

Published: November 18, 2016

Elective nodal irradiation is not necessary in chemoradiotherapy for postoperative loco-regional recurrent esophageal cancer.

Journal: Japanese journal of clinical oncology

Published: November 07, 2016

Renal atrophy after stereotactic body radiotherapy for renal cell carcinoma.

Journal: Radiation oncology (London, England)

Published: December 27, 2015

Metabolic tumor volume on FDG-PET/CT is a possible prognostic factor for Stage I lung cancer patients treated with stereotactic body radiation therapy: a retrospective clinical study.

Journal: Journal of radiation research

Published: September 01, 2015